Nominations Open for BOC’s Certificant of the Year Award
OWINGS MILLS, Md. (Feb. 3, 2025) – The Board of Certification/Accreditation (BOC) is calling for nominations for its Certificant of the Year Award. The award recognizes one BOC-certified individual for outstanding achievements in service, research and outreach. “Our Certificant of the Year Award program remains a distinguished opportunity to honor the exceptional skills and contributions […]
Who Are the “50 Most Influential Leaders in Pharmacy” for 2024?
Pharmacy Podcast Network Announces the “50 Most Influential Leaders in Pharmacy” for 2024 BROWNSVILLE, PA / January 31, 2025 / The “Pharmacy 50” Awards, recognizing the 50 Most Influential Leaders in Pharmacy, have officially been announced for 2024! This prestigious honor celebrates the most inspiring, innovative, and impactful figures in pharmacy who are driving advancements […]
SDS Rx Announces David W. Emison as President
New Leadership Position Focuses on Driving Innovation, Growth, and Service Excellence TAMPA, FL (Jan. 31, 2025) – SDS Rx, a leader in last-mile logistics for the healthcare industry, proudly announces the appointment of David W. Emison as President, effective immediately. In this newly created critical leadership role, Emison will report directly to Drew Kronick, Chief […]
PharmaPoint Rolls Out Version 8.0 of XchangePoint Solution
Birmingham, Ala., January 28, 2025 – PharmaPoint is excited to announce the upcoming rollout of XchangePoint Version 8.0. The next generation solution will feature updates to standardize the look and feel for optimal efficiency, customizable survey links, automation of post discharge documentation and enhanced reporting and analytics. “The cyclical process of gathering feedback from our […]
Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
January 23, 2025 Approval of three important therapies for dementia, oncology and gastrointestinal disease Granted 180-day exclusivity for memantine/donepezil extended-release capsules Tentative approval of rifaximin, a product for treating IBS-D BRIDGEWATER, N.J.–Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil 14-10 mg […]
Omnicell Announces OmniSphere
Next-generation, cloud native, software workflow engine and data platform intended to seamlessly integrate enterprise robotics and smart devices across the continuum of care Company Showcases New and Enhanced Outcomes-Centric Innovation at ASHP Midyear 2024 FORT WORTH, Texas– Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, […]
BOC Board Announces 2025 Executive Committee and New Members
BOC’s Board Chair Cameron Stewart, BOCO, BOCP (View/Download) OWINGS MILLS, Md. (Jan. 27, 2025) –The Board of Certification/Accreditation (BOC) proudly announces the Board of Directors’ 2025 Executive Committee, election of two new members and long-standing leader and Immediate Past Chairman, Wayne R. Rosen’s retirement. Members of the BOC Executive Committee for 2025 include: • Chairman: […]
ProxsysRx Announces Strategic Combination With Maxor National Pharmacy Services
Birmingham’s ProxsysRx has agreed to a strategic combination with Maxor National Pharmacy Services (“Maxor”), positioning the combined entity as the largest independent provider of pharmacy management services to health systems, hospitals, clinics, and other provider organizations. “I’m incredibly excited about this new chapter with Maxor,” said George Salem, CEO of ProxsysRx. “Our organizations have a […]
Endo Launches Doxycycline for Injection, USP
MALVERN, Pa., Dec. 10, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today that it has begun shipping doxycycline for injection, USP 100 mg/vial, an AP-rated version of DOXY 100™. “We’re pleased to provide choices to healthcare providers and hospital pharmacies as they work to deliver quality patient care,” said Scott Sims, Senior Vice President […]
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
November 21, 2024 Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in developing GLP-1 injectables BRIDGEWATER, N.J.–(BUSINESS WIRE)– Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced the advancement of two key strategic initiatives. First, the Company has resubmitted to […]
